Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

But what is Herceptin, and what can it do? Herceptin is the brand name of the ... a week or once every three weeks. Because the drug does not affect normal cells the side effects tend to be ...

Chicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS. Industry: Generic Drugs.

The O'Hern sisters helped each other fight breast cancer. Now they're walking in the 2025 Kentucky Oaks Survivors Parade at ...

Creatine plays an important role in supplying the brain with energy. Early research indicates high doses of the supplement ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

Despite the impact of the pandemic on cancer care, Perjeta grew 17% to CHF 2.9 billion ($3.2 billion) in the first nine months of 2020, now just fractionally behind Herceptin which declined 31% to ...

The biggest advantage is that you can do this at home with as little as a muslin washcloth or a homemade scrub and get immediate results. However, if done too harshly, physical exfoliation can ...

Read on to learn more about what a perfusionist does. Perfusionists are not medical ... They are not doctors, so they do not work alone or make treatment decisions. Instead, perfusionists work ...

At most firms, year-end self-appraisals consist of fee earners’ perspectives on their own performance, but Baker McKenzie does things differently. It asks its partners to not just report on ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...